Cholangiocarcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Not yet recruiting
  • Cholangiocarcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-11-18
Nov 18, 2021
B
Recruiting
  • Gastrointestinal Neoplasms
  • +2 more
  • BI 905711
  • New Haven, Connecticut
  • +7 more
2021-11-18
Nov 18, 2021
N
Recruiting
  • Hepatocellular Carcinoma
  • +2 more
    • San Diego, California
    • +6 more
    2021-11-18
    Nov 18, 2021
    N
    Recruiting
    • Acinar Cell Carcinoma
    • +93 more
    • Biospecimen Collection
    • +2 more
    • Birmingham, Alabama
    • +982 more
    2021-11-18
    Nov 18, 2021
    M
    Recruiting
    • Uterine Cervical Neoplasms
    • +7 more
    • Pembrolizumab/Vibostolimab Co-Formulation
    • +5 more
    • Duarte, California
    • +20 more
    2021-11-18
    Nov 18, 2021
    Z
    Recruiting
    • Ovarian Cancer
    • +5 more
      • Houston, Texas
        MD Anderson Cancer Center
      2021-11-05
      Nov 5, 2021
      M
      Active, not recruiting
      • Colorectal Cancer
      • Cholangiocarcinoma
      • Medtronic pump and Codman catheter
      • +6 more
      • Basking Ridge, New Jersey
      • +6 more
      2021-11-17
      Nov 17, 2021
      A
      Recruiting
      • Breast Cancer
      • +3 more
      • Duarte, California
      • +5 more
      2021-11-05
      Nov 5, 2021
      E
      Recruiting
      • Cholangiocarcinoma
      • +3 more
      • Phoenix, Arizona
      • +32 more
      2021-11-16
      Nov 16, 2021
      J
      Active, not recruiting
      • Esophageal Adenocarcinoma
      • +4 more
      • Antwerpen, Belgium
      • +10 more
      2021-11-16
      Nov 16, 2021
      N
      Recruiting
      • Colorectal Neoplasms
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2021-11-16
        Nov 16, 2021
        M
        Recruiting
        • Advanced Solid Tumor
        • +21 more
        • MDNA11 Monotherapy
        • MDNA11 in combination with checkpoint inhibitor
        • Camperdown, New South Wales, Australia
        • +4 more
        2021-11-15
        Nov 15, 2021
        N
        Active, not recruiting
        • Biliary Tract Neoplasms
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2021-11-13
        Nov 13, 2021
        I
        Active, not recruiting
        • Lung Cancer
        • +10 more
        • Birmingham, Alabama
        • +19 more
        2021-11-11
        Nov 11, 2021
        N
        Recruiting
        • Colon Cancer
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2021-11-09
        Nov 9, 2021
        C
        Recruiting
        • Non-small Cell Lung Cancer
        • +13 more
        • Atlanta, Georgia
        • +4 more
        2021-11-08
        Nov 8, 2021
        T
        Recruiting
        • Solid Tumor
        • +11 more
        • TRK-950
        • +14 more
        • Scottsdale, Arizona
        • +6 more
        2021-11-02
        Nov 2, 2021
        P
        Recruiting
        • Cholangiocarcinoma
        • Fimaporfin and Gemcitabine
        • Gemcitabine/Cisplatin chemotherapy
        • Duarte, California
        • +49 more
        2021-11-03
        Nov 3, 2021
        S
        Recruiting
        • Acinar Cell Carcinoma
        • +7 more
        • Pancreatectomy
        • Lavage
        • Cleveland, Ohio
        • +1 more
        2021-11-02
        Nov 2, 2021
        A
        Active, not recruiting
        • Cholangiocarcinoma
        • CAPECITABINE-Radiotherapy -Liver Transplantation
        • RESECTION
        • Villejuif, France
          AP-HP, Paul Brousse Hospital, Centre Hepato-Biliaire
        2021-11-02
        Nov 2, 2021
        H
        Recruiting
        • Cholangiocarcinoma
        • Combination of Lonsurf® and Irinotecan
        • Düsseldorf, NRW, Germany
          Klinik für Gastroenterologie, Hepatologie und Infektiologie
        2021-10-25
        Oct 25, 2021
        E
        Recruiting
        • Locally Advanced Solid Tumor
        • +16 more
        • Birmingham, Alabama
        • +29 more
        2021-10-28
        Oct 28, 2021